Related Experiment Video
Updated: Jun 17, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease
Anne J Blaschke1, Laurie S Pulver, E Kent Korgenski
1Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. anne.blaschke@hsc.utah.edu
Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing.
Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Development of the Oral Microbiota
Mechanism of Antibiotic Resistance in MRSA
Streptococcal Pharyngitis
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
